SOURCE: Leerink Swann & Company

June 14, 2005 09:19 ET

Leerink Swann & Company Initiates Coverage of Dade Behring Holdings, Inc. (NASDAQ: DADE)

BOSTON, MA -- (MARKET WIRE) -- June 14, 2005 -- This morning, Senior Diagnostics and Medical Supplies Analyst Bruce Cranna, initiated coverage of Dade Behring Holdings, Inc. with a Market Perform rating. Although Dade Behring has reported several solid quarters since emerging from bankruptcy in 2002, Mr. Cranna bases his investment thesis on his belief that the company is fairly valued at present. Dade Behring is expanding into the high volume immunochemistry market with The Vista, a 1,500 test per hour platform, and Mr. Cranna estimates that the sales benefits from The Vista, with its targeted launch of mid 2006, will be realized in 2007.

About Dade Behring Holdings, Inc.

With 2004 revenues of $1.6 billion, Dade Behring Holdings, Inc. (NASDAQ: DADE) is the world's largest company dedicated solely to clinical diagnostics. The company has four core product lines: Chemistry/Immunochemistry, Hemostasis, Microbiology and Infectious Disease Diagnostics and is headquartered in Deerfield, Illinois.

About Leerink Swann & Company

Leerink Swann & Company is an investment banking firm that provides healthcare equity research, corporate finance, and asset management services for institutional and high-net-worth clients. Leerink Swann & Company was voted the Best Firm in Biotechnology, Medical Supplies and Devices, Pharmaceuticals/Major and Pharmaceuticals/Specialty in the December 2004 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. MEDACorp includes thousands of biomedical professionals and practicing physicians. Leerink Swann & Company is a member NASD/SIPC.

Contact Information